vs

Side-by-side financial comparison of Arcutis Biotherapeutics, Inc. (ARQT) and SunPower Inc. (SPWR). Click either name above to swap in a different company.

Arcutis Biotherapeutics, Inc. is the larger business by last-quarter revenue ($129.5M vs $79.7M, roughly 1.6× SunPower Inc.). Arcutis Biotherapeutics, Inc. runs the higher net margin — 13.4% vs -17.8%, a 31.2% gap on every dollar of revenue. On growth, Arcutis Biotherapeutics, Inc. posted the faster year-over-year revenue change (81.5% vs -10.1%). Over the past eight quarters, SunPower Inc.'s revenue compounded faster (118.7% CAGR vs 70.1%).

Arcutis Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative prescription therapies for immune-mediated dermatological diseases. Its core product portfolio targets conditions including psoriasis, atopic dermatitis, and alopecia areata, primarily serving patients and healthcare providers across the United States, addressing unmet needs in the dermatology care segment.

SunPower Corporation is an American provider of photovoltaic solar energy generation systems and battery energy storage products, primarily for residential customers. The company, headquartered in San Jose, California, was founded in 1985 by Richard Swanson, an electrical engineering professor from Stanford University. Cypress Semiconductor bought a majority interest in the company in 2002, growing it quickly until SunPower went public in 2005. TotalEnergies, a French energy and oil company p...

ARQT vs SPWR — Head-to-Head

Bigger by revenue
ARQT
ARQT
1.6× larger
ARQT
$129.5M
$79.7M
SPWR
Growing faster (revenue YoY)
ARQT
ARQT
+91.6% gap
ARQT
81.5%
-10.1%
SPWR
Higher net margin
ARQT
ARQT
31.2% more per $
ARQT
13.4%
-17.8%
SPWR
Faster 2-yr revenue CAGR
SPWR
SPWR
Annualised
SPWR
118.7%
70.1%
ARQT

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
ARQT
ARQT
SPWR
SPWR
Revenue
$129.5M
$79.7M
Net Profit
$17.4M
$-14.2M
Gross Margin
91.0%
35.5%
Operating Margin
14.2%
-27.4%
Net Margin
13.4%
-17.8%
Revenue YoY
81.5%
-10.1%
Net Profit YoY
-130.1%
EPS (diluted)
$0.13
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARQT
ARQT
SPWR
SPWR
Q2 26
$129.5M
Q1 26
$105.4M
Q4 25
$129.5M
$79.7M
Q3 25
$99.2M
$22.0M
Q2 25
$81.5M
$67.5M
Q1 25
$65.8M
$82.7M
Q4 24
$71.4M
$88.7M
Q3 24
$44.8M
Net Profit
ARQT
ARQT
SPWR
SPWR
Q2 26
$17.4M
Q1 26
$-11.3M
Q4 25
$17.4M
$-14.2M
Q3 25
$7.4M
$-16.9M
Q2 25
$-15.9M
$-22.4M
Q1 25
$-25.1M
$8.1M
Q4 24
$-10.8M
$47.0M
Q3 24
$-41.5M
Gross Margin
ARQT
ARQT
SPWR
SPWR
Q2 26
91.0%
Q1 26
90.7%
Q4 25
91.0%
35.5%
Q3 25
91.2%
Q2 25
90.8%
42.6%
Q1 25
86.6%
48.5%
Q4 24
90.3%
46.5%
Q3 24
87.7%
Operating Margin
ARQT
ARQT
SPWR
SPWR
Q2 26
14.2%
Q1 26
-8.6%
Q4 25
14.2%
-27.4%
Q3 25
8.6%
-15.7%
Q2 25
-17.9%
-4.0%
Q1 25
-37.3%
1.3%
Q4 24
-10.7%
-24.2%
Q3 24
-87.3%
Net Margin
ARQT
ARQT
SPWR
SPWR
Q2 26
13.4%
Q1 26
-10.7%
Q4 25
13.4%
-17.8%
Q3 25
7.5%
-76.9%
Q2 25
-19.5%
-33.2%
Q1 25
-38.1%
9.8%
Q4 24
-15.1%
53.0%
Q3 24
-92.8%
EPS (diluted)
ARQT
ARQT
SPWR
SPWR
Q2 26
$0.13
Q1 26
$-0.09
Q4 25
$0.14
$-0.05
Q3 25
$0.06
$-0.19
Q2 25
$-0.13
$-0.28
Q1 25
$-0.20
$0.00
Q4 24
$-0.09
$0.27
Q3 24
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARQT
ARQT
SPWR
SPWR
Cash + ST InvestmentsLiquidity on hand
$42.9M
$9.6M
Total DebtLower is stronger
$164.8M
Stockholders' EquityBook value
$189.5M
$-90.1M
Total Assets
$433.0M
$241.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARQT
ARQT
SPWR
SPWR
Q2 26
$42.9M
Q1 26
$34.8M
Q4 25
$42.9M
$9.6M
Q3 25
$47.1M
$5.1M
Q2 25
$72.7M
$11.1M
Q1 25
$53.1M
$10.6M
Q4 24
$71.3M
$13.4M
Q3 24
$134.9M
Total Debt
ARQT
ARQT
SPWR
SPWR
Q2 26
Q1 26
Q4 25
$109.0M
$164.8M
Q3 25
$108.5M
$204.3M
Q2 25
$108.0M
$152.9M
Q1 25
$107.6M
Q4 24
$107.2M
$147.3M
Q3 24
$204.6M
Stockholders' Equity
ARQT
ARQT
SPWR
SPWR
Q2 26
$189.5M
Q1 26
$189.6M
Q4 25
$189.5M
$-90.1M
Q3 25
$158.1M
$-112.3M
Q2 25
$139.0M
$-107.2M
Q1 25
$142.7M
$-89.0M
Q4 24
$157.5M
$-97.5M
Q3 24
$156.6M
Total Assets
ARQT
ARQT
SPWR
SPWR
Q2 26
$433.0M
Q1 26
$460.0M
Q4 25
$433.0M
$241.2M
Q3 25
$371.0M
$208.3M
Q2 25
$352.4M
$163.1M
Q1 25
$344.1M
$147.8M
Q4 24
$348.9M
$144.5M
Q3 24
$437.4M
Debt / Equity
ARQT
ARQT
SPWR
SPWR
Q2 26
Q1 26
Q4 25
0.58×
Q3 25
0.69×
Q2 25
0.78×
Q1 25
0.75×
Q4 24
0.68×
Q3 24
1.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARQT
ARQT
SPWR
SPWR
Operating Cash FlowLast quarter
$-1.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARQT
ARQT
SPWR
SPWR
Q2 26
Q1 26
Q4 25
$26.2M
$-1.9M
Q3 25
$-1.8M
$-6.4M
Q2 25
$324.0K
$-4.4M
Q1 25
$-30.4M
$-2.6M
Q4 24
$-748.0K
$-25.6M
Q3 24
$-34.7M
Free Cash Flow
ARQT
ARQT
SPWR
SPWR
Q2 26
Q1 26
Q4 25
Q3 25
Q2 25
$246.0K
Q1 25
$-31.0M
Q4 24
Q3 24
$-34.8M
FCF Margin
ARQT
ARQT
SPWR
SPWR
Q2 26
Q1 26
Q4 25
Q3 25
Q2 25
0.3%
Q1 25
-47.1%
Q4 24
Q3 24
-77.8%
Capex Intensity
ARQT
ARQT
SPWR
SPWR
Q2 26
Q1 26
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.9%
Q4 24
0.0%
Q3 24
0.3%
Cash Conversion
ARQT
ARQT
SPWR
SPWR
Q2 26
Q1 26
Q4 25
1.51×
Q3 25
-0.24×
Q2 25
Q1 25
-0.32×
Q4 24
-0.54×
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARQT
ARQT

Segment breakdown not available.

SPWR
SPWR

Residential Solar Installation$46.9M59%
New Homes Business$22.7M29%
Other$10.1M13%

Related Comparisons